Javier Hornedo

Hospital Universitario Quirónsalud Madrid — Spain

Medicine · Health Sciences

22h-index1.7kcitations65works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(17), Neutropenia and Cancer Infections(15), Breast Cancer Treatment Studies(12), Cancer Cells and Metastasis(7), Hematopoietic Stem Cell Transplantation(7)

Publications65 total

Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement
EClinicalMedicine·2023· 50 citedOpen Access
Patterns of Relapse Related to High Expression of Ki-67 After Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Journal of Gynecology and Obstetrics·2021Open Access
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trial
Breast Cancer Research·2020· 28 citedOpen Access
Impact of 68Ga-PSMA PET/CT in the treatment of prostate cancer: Initial experience in Spain
Reports of Practical Oncology & Radiotherapy·2020· 3 citedOpen Access
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
Breast Cancer Research·2019· 22 citedOpen Access
Addition of durvalumab (Dur) upon progression to bevacizumab (Bev) maintenance in advanced HER2-negative (HERNEG) breast cancer (BC): Safety, efficacy and biomarkers
Annals of Oncology·2018· 5 citedOpen Access
EP-1285: Immediate breast reconstruction followed by adjuvant radiotherapy. Aesthetics and Quality of life
Radiotherapy and Oncology·2018Open Access
Abstract OT2-07-02: CNIO-BR-009 trial: Targeting mitochondrial metabolism with ME-344 in breast cancer upon bevacizumab-induced vascular normalization: A phase 0 randomized clinical trial
Cancer Research·2018· 1 cited
Association between distinct intratumoral and stromal tumor infiltrating immune cells and pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
Journal of Clinical Oncology·2016· 1 cited
PO-0736: Tumour staging using MRI in prostate cancer: improvement of treatment decisions for radiotherapy
Radiotherapy and Oncology·2016Open Access
EUFORIA study (Eribulin Use for the Treatment of Advanced Breast Cancer: Observational, Retrospective Analysis): Initial experience with eribulin in daily clinical practice in Spain.
Journal of Clinical Oncology·2013· 1 cited
Magnetic resonance imaging (MRI) evaluation of pathologic complete response (pCR) in different breast cancer subtypes after neoadjuvant chemotherapy (NAC).
Journal of Clinical Oncology·2012· 3 cited
Long-Term Follow-Up of an Anthracycline-Containing Metronomic Chemotherapy Schedule in Advanced Breast Cancer
The Breast Journal·2009· 12 cited
Vitamin E protects against the mitochondrial damage caused by cyclosporin A in LLC-PK1 cells
Toxicology and Applied Pharmacology·2009· 32 cited
Novel chemotherapy approaches in chemoradiation protocols
Gynecologic Oncology·2008· 19 cited
[Cyclosporin A causes oxidative stress and mitochondrial dysfunction in renal tubular cells].
PubMed·2007· 32 cited
Randomized Study of Cefepime versus Ceftazidime plus Amikacin in Patients with Solid Tumors Treated with High Dose Chemotherapy (HDC) and Peripheral Blood Stem Cell Support (PBSCS) with Febrile Neutropenia
Clinical & Translational Oncology·2006· 5 cited
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domain
Clinical & Translational Oncology·2006· 9 cited
Breast Cancer–Specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-Risk Breast Cancer Patients Treated With High-Dose Chemotherapy With Peripheral Blood Stem Cell Support
Journal of Clinical Oncology·2006· 37 citedOpen Access
Flow cytometric analysis of the in situ hybridization of cyclooxygenase isoforms in mesangial cells treated with cyclosporine A
Cytometry Part A·2006· 1 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

H. Cortés-Funes(23), Rámón Colomer(21), Carlos Lumbreras(8), Manuel Hidalgo(7), Lucía González‐Cortijo(7), Alberto Arcediano(6), Ricardo Hitt(6), Rocio García‐Carbonero(5), José Trigo(5), Aňa Lluch(5), Miguel Quintela-Fandiño(5), José Mayordomo(4), Ana Ruiz‐Casado(4), J Garcı́a-Conde(4), Silvana Mourón(4), Sofía Perea(4), María Victoria Tornamira(3), José Luis Perez‐Gracia(3), B. Ojeda(3), C. Mendiola(3)